Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,670 | 3,000 | 3,330 | N/A | N/A |
| Depreciation Amortization | 450 | 1,460 | 960 | N/A | N/A |
| Other Working Capital | 1,410 | 4,280 | 4,770 | N/A | N/A |
| Other Operating Activity | -1,090 | 30 | 20 | 0 | 0 |
| Operating Cash Flow | $-900 | $8,770 | $9,080 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 40 | -1,430 | -1,070 | N/A | N/A |
| Investing Cash Flow | $40 | $-1,430 | $-1,070 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 70 | 400 | 140 | 0 | 0 |
| Financing Cash Flow | $70 | $400 | $140 | $N/A | $N/A |
| Exchange Rate Effect | 570 | 1,470 | 1,160 | N/A | N/A |
| Beginning Cash Position | 14,520 | 5,300 | 5,300 | N/A | N/A |
| End Cash Position | 14,310 | 14,520 | 14,620 | N/A | N/A |
| Net Cash Flow | $-200 | $9,210 | $9,310 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -900 | 8,770 | 9,080 | N/A | N/A |
| Free Cash Flow | -900 | 8,770 | 9,080 | 0 | 0 |